Moreover, CD44 contributed to the progressive fibrotic phenotype because lung fibrosis was reduced by either crossing the α-SMA-HAS2 transgenic mouse with the CD44 deficient mouse or by treatment with a blocking antibody to CD44. The gene discussed is ACTA1; the disease is pulmonary fibrosis.